HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC
The α3 mutation significantly reduces the binding of MHC tetramer to human CD8. To minimizes the aberrant effect of some CD8 antibodies; clone SFCI21Thy2D3 (also known as “T8”) is recommended.
| Target | Cancer |
|---|---|
| Product Type | Tetramer |
| Application | FCM |
| Conjugate | APC |
| Class | Class I |
| Species Reactivity | Human |
| Allele | HLA-A*24:02 |
| Peptide Sequence | LY6K |
| Research Area | Immunology, Immune Monitoring |
| Protocols | FCM |
| Specificity | LY6K |
| Regulatory Statement | For Research Use Only. Not for use in diagnostic procedures. |
Related Products
Related Content
